The Authors' Reply
Year of publication: |
2006
|
---|---|
Authors: | Bagust, Adrian A. ; Evans, Marc ; Beale, Sophie ; Home, Philip ; Perry, Andrew ; Stewart, Murray ; Shearer, Arran ; Martin, Alan ; Hulme, Lisa ; Liebl, Andreas ; Schoeffski, Oliver ; Goertz, Anita ; Ampudia-Blasco, Javier ; Martinez-Lage, Belen ; Perez Escolano, Isabel ; Paris, Gonzalo |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 24.2006, 9, p. 929-935
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Cost-utility | Metformin | Modelling | Rosiglitazone | Type-2-diabetes-mellitus |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Palmer, Andrew J., (2006)
-
Ramsdell, Joe W., (2003)
-
Cost Effectiveness of Preventive Screening Programmes for Type 2 Diabetes Mellitus in Germany
Schaufler, Thilo M., (2010)
- More ...
-
Bagust, Adrian, (2006)
-
Bagust, Adrian, (2006)
-
Cost-effectiveness of Rosiglitazone Oral Combination for the Treatment of Type 2 Diabetes in Germany
Shearer, Arran, (2006)
- More ...